Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAGENT PHARMS INC

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 45
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 49
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

PROVEPHARM SAS

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 45
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 59
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

ACS DOBFAR SPA

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 51
  • 0 comments

FDA approve AMPICILLIN SODIUM

Comment Full text

STERISCIENCE

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 54
  • 0 comments

FDA approve AMPICILLIN SODIUM

Comment Full text

ISTITUTO BIO ITA SPA

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 51
  • 0 comments

FDA approve AMPICILLIN SODIUM

Comment Full text

PAR STERILE PRODUCTS

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 45
  • 0 comments

FDA approve DEXMEDETOMIDINE HYDROCHLORIDE

Comment Full text

SANDOZ

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 50
  • 0 comments

FDA approve PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Comment Full text

ACS DOBFAR SPA

  • FDA Approval
  • May 03, 2024, 08:49 UTC
  • 44
  • 0 comments

FDA approve AMPICILLIN SODIUM

Comment Full text
  • Previous
  • 459
  • 460
  • 461
  • 462
  • 463
  • Next

Search

News categories

  • Technical Exchange News(14691)
  • Event(6229)
  • SEC News(393533)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239469)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin